Trial Profile
A Phase IV, Randomized, Double Blind Study Evaluating the Safety and Efficacy of Apixaban in Subjects With Calf Vein Thrombosis
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 27 Mar 2020
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Deep vein thrombosis
- Focus Therapeutic Use
- 10 Mar 2020 Status changed from recruiting to discontinued.
- 11 Dec 2018 Status changed from not yet recruiting to recruiting.
- 24 Jul 2018 New trial record